• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Development of methods that facilitate generation of recombinant herpesviruses using BAC system

Research Project

Project/Area Number 12556049
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Basic veterinary science/Basic zootechnical science
Research InstitutionNagoya University (2002)
Tokyo Medical and Dental University (2000-2001)

Principal Investigator

KAWAGUCHI Yasushi  Nagoya University, Graduate School of Medicine, Associate Professor, 大学院・医学系研究科, 助教授 (60292984)

Co-Investigator(Kenkyū-buntansha) MAEDA Ken  Yamaguchi University, Faculty of Agriculture, Associate Professor, 農学部, 助教授 (90284273)
HORIMOTO Taisuke  The University of Tokyo, The institute of mideical science, Associate Professor, 医科学研究所, 助教授 (00222282)
MIKAMI Takeshi  Nippon University College of Biosource Science, Professor, 生物資源科学部, 教授 (20091506)
TANAKA Michiko  National institute for infectious diseases, Researcher, 感染病理部, 研究員 (10356248)
TOHYA Yukinobu  The university of Tokyo, Graduate School of Agricultural and life science, Associate Professor, 大学院・農学生命科学研究科, 助教授 (20180119)
Project Period (FY) 2000 – 2002
Keywordsherpesviruses / reverse genetics / BAC system
Research Abstract

In recent years, several laboratories have reported on the cloning of herpesvirus genomes as bacterial artificial chromosomes (BACs) in E. coli and on procedures to manipulate these genomes using the bacterial recombination machinery. However, the herpesvirus-BACs reported so far are either replication-incompetent or infectious with a deletion of one or more viral genes due to the BAC vector insertion. As a multi-purpose clone for use in the research of herpesviruses, we attempted to generate infectious herpes simplex virus (HSV) -BACs containing the full genome of HSV-1 without any loss of^viral genes. Our results were as follows. (i)E. coli (YEbac102) harboring the full-length HSV-1 genome (pYEbac102) in which a BAG, flanked by loxP sites were inserted into the intergenic region between U_L3 and U_L4 was constructed, (ii) pYEbac102 was an infectious molecular clone, given that its transfection into rabbit skin cells resulted in production of infectious virus (YK304). (iii)' The BAC vector sequence was almost perfectly excisable from the genome of the reconstituted virus YK304 by co-infection of Vero cells with YK304 and a recombinant adenovirus AxCANCre expressing Cre recombinase. (iv) As far as was examined, the reconstituted viruses from pYEbac102 could not be phenotypically differentiated from wild-type viruses in vitro and in vivo. Thus the viruses grew as well in Vero cells as did the wild-type virus and exhibited wild-type virulency in mice on intracerebral inoculation. (v) The infectious molecular clone pYEbac102 is in fact useful for mutagenesis of the HSV-1 genome by bacterial genetics and a recombinant virus carrying amino acid substitutions in both copies of the αO gene was generated. pYEbac102 will be multi-applicable to the rapid generation of genetically engineered HSV-1 recombinants in basic research into HSV-1 and in the development of HSV vectors in human therapy.

  • Research Products

    (50 results)

All Other

All Publications (50 results)

  • [Publications] 川口 寧: "αヘルペスウイルス遺伝子関連事項:遺伝子発現制御機構"日本臨床. 58. 779-786 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Sonoda: "Development of effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type in commercial chickens with maternal antibodies"Journal of Virology. 74. 3217-3226 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Kawaguchi: "Interaction of Epstein-Barr Virus nulear antigen leader protein (EBNA-LP) with HS1-associated protein X-1 : Implication of cytoplasmic function of EBNA-LP"Journal of Virology. 74. 10104-10111 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sato E: "Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline herpesvirus type 1 (FHV-1) using the gC promoter of FHV-1"Virus Res.. 70. 12-23 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yasunaga S: "Application of a type-specific enzyme-linked immunosorbent assay for equine herpesvirus types 1 and 4 (EHV-1 and -4) to horse populations inoculated with inactivated EHV-1 vaccine"J. Vet. Med. Sci.. 62. 687-691 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 前田 健: "αヘルペスウイルス感染症に対するDNAワクチン"日本臨床. 58. 933-928 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mishima M: "Recombinant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats"Parasitol Res.. 88. 144-149 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Damiani AM: "Identification of the products of the equine herpesvirus type 4 gI and gE genes"Archives of Virology. 145. 1489-1496 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Damiani AM: "A deletion in the gI and gE genes of equine herpesvirus type 4 reduces viral virulence in the natural host and affects virus transmission during cell-to-cell spread"Virus Res.. 67. 189-202 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 横山尚明: "組み換えヘルペスウイルスのワクチン応用"日本臨床. 58. 944-950 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A.Yokoyama et al.: "The Conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not on nuclear matrix association but also for nuclear localization"Virology. 279. 401-413 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawaguchi et al.: "Herpes simplex virus type a regulatory protein ICP0 functionally inter acts with a cellular transcription factor BMAL1"Proc. Natl. Acad. Sci. USA. 98. 1877-1882 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 川口 寧: "ヘルペスウイルス遺伝子発現制御因子の機能発現機構の解明"ウイルス. 52. 207-216 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishikawa Y: "Canine herpesvirus ORF2 is a membrane protein modified by N-linked glycosylation"Virus Res.. 87. 1-9 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Kawaguchi et al.: "Conserved Protein Kinases Encoded by Herpesviruses and a Cellular Protein Kinase Cdc2 Target the Same Phosphorylation Site In Eukaryotic Elongation Factor 1δ"Journal of Virology. 77. 2359-2368 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Tanaka et al.: "Construction of an Excisable Bacterial Artificial Chromosome Containing a Full-Length Infectious Clone of Herpes Simplex Virus Type 1 : Viruses Reconstituted from the Clone Exhibits Wild-Type Properties In Vitro and In Vivo"Journal of Virology. 77. 1382-1391 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Igarashi et al.: "Physical interaction of Epstein-Barr Virus (EBV) nuclear antigen leader protein (EBNA-LP) with human estrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization"Journal of General Virology. 84. 319-327 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] G.Matsuda et al.: "Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein bel-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1"Microbiology and Immunology. 49. 91-99 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Kato et al.: "Epstein-Barr virus encoded-protein kinase BGLF mediates hyper-phosphorylation of cellular el factor1δ (EF-1δ) : EF-1δ is universally modified by conserved protein kinases of herpesviruses"Journal of General Virology. 82. 1457-1463 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] A.Yokoyama et al.: "Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (LP): The function of EBNA-LP to induce latent membrane protein 1 co-operatively with EBNA-2 is re lated by phosphorylation"Journal of Virology. 75. 5119-5128 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sato E: "Further development of a recombinant feline herpesvirus type 1 expressing the Gag protein of feline immunodeficiency virus"Archives of Virology. 146. 379-387 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Rupasinghe V: "Identification of the porcine cytomegalovirus major capsid protein gene."J. Vet. Med. Sci.. 63. 609-618 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Tanaka et al.: "The Conserved region CR2 of Epstein-Barr Virus Nuclear Antigen Leader Protein Is a Multifunctional Domain that mediates Self-Association As Well As Nuclear Localization and Nuclear Matrix Association"Journal of Virology. 76. 1025-1032 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Kato et al.: "Characterization of the regulatory function of the Marek's disease virus serotype 1 ICP22 homologue"Veterinary Microbiology. 85. 305-313 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Kato: "Conserved protein kinases encoded by herpesviruses : The viral protein kinases play specific and conserved roles in replication cycles of respective herpesviruses"Reviews in Medical Virology. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Kawaguchi: "Regulation of alphaherpesvirus gene expression"Nippon Rinsho. 58. 779-786 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Sonoda, M.Sakaguchi, H.Okamura, K.Yokogawa, E.Tokunaga, S.Tokiyoshi, Y.Kawaguchi, and K.Hirai: "Development of effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type in commercial chickens with maternal antibodies"J.Virol. 74. 3217-3226 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Kawaguchi, K.Nakajima, M.Igarashi, T.Morita, M.Tanaka, M.Suzuki, A.Yokoyama, G.Matsuda, K.Kato, M.Kanamori, and K.Hirai: "Interaction of Epstein-Barr Virus nulear antigen leader protein (EBNA-LP) with HS1-associated protein X-1 : Implication of cytoplasmic function of EBNA-LP"J.Virol. 74. 10104-10111 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato E, Yokoyama N, Miyazawa T, Maeda K, Ikeda Y, Nishimura Y, Fujita K, Kohmoto M, Takahashi E, Mikami T: "Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline hrpesvirus type 1 (FHV-1) using the gC promoter of FHV-1"Virus Res. 70(1-2). 13-23 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yasunaga S, Maeda K, Matsumura T, Kondo T, Kai K: "Application of a type-specific enzyme-linked immunosorbent assay for equine herpesvirus types 1 and 4 (EHV-1 and -4) to horse populations inoculated with inactivated EHV-1 vaccine"J Vet Med Sci. 62(7). 687-691 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ken Maeda: "DNA vaccines against alphaherpesvirus infections"Nippon Rinsho Å@. 58. 933-928 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mishima M, Xuan X, Yokoyama N, Igarashi I, Fujisaki K, Nagasawa H, Mikami T: "Recombinant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats"Parasitol Res. 88. 144-149

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Damiani AM, Matsumura T, Jang HK, Izumiya Y, Mikami T, Takahashi E: "Identification of the products of the equine herpesvirus type 4 gI and gE genes"Arch Virol. 145(7). 1489-1496 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Damiani AM, Matsumura T, Yokoyama N, Mikami T, Takahashi E: "A deletion in the gI and gE genes of equine herpesvirus type 4 reduces viral virulence in the natural host and affects virus transmission during cell-to-cell spread"Virus Res. 67(2). 189-202 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Naoaki Yokoyama, Xuenan Xuan and Takeshi Mikami: "Vaccine application of recombinant herpesviruses"Nippon Rinsho Å@. 58. 944-950 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] A.Yokoyama, Y.Kawaguchi, I.Kitabayashi, M.Ohki, and K.Hirai: "The Conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization"Virology. 279. 401-413 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Kawaguchi, M.Tanaka, A.Yokoymama, G.Matsuda, K.Kato, H.Kagawa, K.Hirai, and B.Roizman: "Herpes simplex virus type 1 α regulatory protein ICPO functionally interacts with a cellular transcription factor BMAL1"Proc.Natl.Acad.Sci.. 98. 1877-1882 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Kato, Y.Kawaguchi, M.Tanaka, Mie Igarashi, Akihiko Yokoyama, Go Matsuda, Mikiko Kanamori, Kaori Nakajima, Yorihiro Nishimura, Masayuki Shimojima, Hang T.T.Phung, Eiji Takahashi, and Kanji Hirai: "Epstein-Barr virus encoded-protein kinase BGLF mediates hyper-phosphorylation of cellular elongation factor1δ (EF-1δ) : EF-1δ is universally modified by conserved protein kinases of herpesviruses"J.Gen.Virol. 82. 1457-1463 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] A.Yokoyama, M.Tanaka, G.Matsuda, K.Kato, M.Kanamori, H.Kawasaki, H.Hirano, I.Kitabayashi, M.Ohki, K.Hirai, and Y.Kawaguchi: "Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) : The function of EBNA-LP to induce latent membrane protein 1 co-operatively with EBNA-2 is regulated by phosphorylation"J.Virol. 75. 5119-5128 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato E, Miyazawa T, Nishimura Y, Ikeda Y, Kawakami K, Mochizuki M, Yokoyama N, Maeda K, Fujita K, Kohmoto M, Takahashi E, Mikami T: "Further development of a recombinant feline herpesvirus type 1 expressing the Gag protein of feline immunodeficiency virus"Arch Virol. 146(2). 379-387 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Rupasinghe V, Iwatsuki-Horimoto K, Sugii S, Horimoto T: "Identification of the porcine cytomegalovirus major capsid protein gene"J Vet Med Sci. 63(6). 609-618 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Tanaka, A.Yokoyama, M.Igarashi, G.Matsuda, K.Kato, M.Kanamori, K.Hirai, Y.Kawaguchi and Yuji Yamanashi: "The Conserved region CR2 of Epstein-Barr Virus Nuclear Antigen Leader Protein Is a Multifunctional Domain that mediates Self-Association As Well As Nuclear Localization and Nuclear Matrix Association"J.Virol. 76. 1025-1032 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Kato, Y.Izumiya, Y.Tohya, E.Takahashi, K.Hirai, and Y.Kawaguchi: "Characterization of the regulatory function of the Marek's disease virus serotype 1 ICP22 homologue"Vet.Microbiol. 85. 305-313 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yausushi Kawaguchi: "Functional analyses of regulatory proteins of herpesviruses"Uirusu. 52. 207-216 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishikawa Y, Kimura M, Xuan X, Makala L, Nagasawa H, Mikami T, Otsuka H: "Canine herpesvirus ORF2 is a membrane protein modified by N-linked glycosylation"Virus Res. 87(1). 1-9 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Kawaguchi, K.Kato, M.Tanaka, M.Kanamori, Y.Nishiyama, and Y.Yamanashi: "Conserved Protein Kinases Encoded by Herpesviruses and a Cellular Protein Kinase Cdc2 Target the Same Phosphorylation Site In Eukaryotic Elongation Factor 1δ"J.Virol. 77. 2359-2368 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Tanaka, H.Kagawa, Y.Yamanashi, T.Sata and Y.Kawaguchi: "Construction of an Excisable Bacterial Artificial Chromosome Containing a Full-Length Infectious Clone of Herpes Simplex Virus Type 1 : Viruses Reconstituted from the Clone Exhibits Wild-Type Properties In Vitro and In Vivo"J.Virol. 77. 1382-1391 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Igarashi, Y.Kawaguchi, K.Hirai, and F.Mizuno: "Physical interaction of Epstein-Barr Virus (EBV) nuclear antigen leader protein (EBNA-LP) with human estrogen-related receptor 1 (hERR1) : hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization"J.Gen.Virol. 84. 319-327 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] G.Matsuda, K.Nakajima, Y.Kawaguchi, Y.Yamanashi and K.Hirai: "Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-l"Microbiol.Immunol. 47. 91-99 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Kato and Y.Kawaguchi: "Conserved protein kinases encoded by herpesviruses : The viral protein kinases play specific and conserved roles in replication cycles of respective herpesviruses"Reviews in Medical Virology. (in press). (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi